Table 1 |
|||
|
Baseline characteristics of the early arthritis population: RA and UA patients |
|||
|
Baseline characteristics |
RA (n = 123) |
UA (n = 39) |
P value |
|
|
|||
|
Age (years)a |
56.4 ± 15.0 |
53.8 ± 14.0 |
NS |
|
Female (%)b |
86 (69.9) |
26 (66.7) |
NS |
|
Disease duration (years)c |
0.4 (0.3 to 0.6) |
0.4 (0.3 to 0.8) |
NS |
|
ESR (mm/hour)a |
36.7 ± 24.4 |
23.7 ± 21.0 |
<0.005 |
|
CRP (mg/dl)c |
19.5 (6.5 to 45.5) |
6 (2 to 15) |
<0.005 |
|
Anti-CCP2 positive (%) |
68 (55.3) |
3 (7.9) |
<0.005 |
|
Anti-MCV positive (%) |
73 (59.3) |
3 (7.7) |
<0.005 |
|
DAS28 scorea |
5.1 ± 1.2 |
4.3 ± 1.2 |
<0.01 |
|
Sharp-van der Heijde scorec |
2 (0 to 6) |
0 (0 to 1) |
<0.01 |
|
HAQ scorea |
1.1 ± 0.7 |
0.8 ± 0.6 |
p < 0.05 |
|
|
|||
|
Data are expressed as mean ± standard deviation or as median (Interquartile range). aTested using Student's t-test. bTested using the χ2 test. cTested using the Mann Whitney U-test. CCP2, second-generation cyclic citrullinated peptide; CRP, C-reactive protein; DAS28, Disease Activity Score of 28 joints; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; MCV, mutated citrullinated vimentin; NS, not significant; RA, rheumatoid arthritis; UA, undifferentiated arthritis. |
|||
|
Ursum et al. Arthritis Research & Therapy 2008 10:R12 doi:10.1186/ar2362 |
|||